The present invention relates to the use of proteins that are differentially expressed in primary brain tumor tissues, as compared to normal brain tissues, as biomolecular targets for brain tumor treatment therapies. Specifically, the present invention relates to the use of immunotherapeutic and immunoimaging agents, which specifically bind to one or more of the identified brain tumor protein targets. The present invention also provides compounds and pharmaceutically acceptable compositions for administration in the methods of the invention. Nucleic acid probes specific for the spliced mRNA encoding these variants and affinity reagents specific for the novel proteins are also provided.

 
Web www.patentalert.com

< Recombinant vector expressing multiple costimulatory molecules and uses thereof

< Implantable, retrievable sensors and immunosensors

> Hyaluronic acid gel, process for producing the same, and medical material containing the same

> Anti-TNF antibodies and peptides of human tumor necrosis factor

~ 00247